Porkodi Karthikeyan, M.V. Dass Prakash, Pavithra Devi Sendurapandi, Kalaiselvi Periandavan
Porkodi Karthikeyan1, M.V. Dass Prakash2, Pavithra Devi Sendurapandi3, Kalaiselvi Periandavan4
1Research Scholar, Department of Medical Biochemistry, Dr. ALMPGIBMS, University of Madras, Taramani Campus, Chennai.
2Assistant Professor, Sri Sankara Arts and Science College (Autonomous), Kanchipuram, Tamil Nadu, India.
3Research Scholar, Department of Biochemistry, Sri Sankara Arts and Science College (Autonomous), Kanchipuram, Tamil Nadu, India.
4Associate Professor, Department of Medical Biochemistry, Dr. ALMPGIBMS, University of Madras, Taramani Campus, Chennai
Volume - 14,
Issue - 9,
Year - 2021
Diabetes Mellitus is a metabolic disorder characterized by elevated blood glucose level caused due to deficiency of insulin secretion or insulin action. The management of the blood glucose level is an important approach in the control of diabetes mellitus complications. There are many divergent therapeutic strategies in the management of Type II diabetes. The inhibition of carbohydrate hydrolyzing enzymes such as a-amylase and a-glucosidase can be used to lower postprandial blood glucose levels. The objective of the present study is to evaluate the inhibitory potential of Gymnemic acid in various concentrations on a-amylase and a-glucosidase activities. Gymnemic acid and voglibose show the IC50 value of 68.12 and 46.23 on alpha amylase and IC50 value of 65.77 and 36.67 on alpha glucosidase activity respectively. Insilico docking study between a-amylase and a-glucosidase with gymnemic acid and voglibose depict the similar amino acid binding sites that substantiate that gymnemic acid might be used as a natural and cost-effective alternative to the synthetic drug. This study throws light on the anti-diabetic action of phytomedicine, Gymnemic acid, a component of Gymnema sylvestre.
Cite this article:
Porkodi Karthikeyan, M.V. Dass Prakash, Pavithra Devi Sendurapandi, Kalaiselvi Periandavan. Assessment of the antidiabetic potential of Gymnemic acid as α-amylase and α-Glucosidase inhibitor using invitro and insilico tools. Research Journal of Pharmacy and Technology. 2021; 14(9):4755-9. doi: 10.52711/0974-360X.2021.00827
Porkodi Karthikeyan, M.V. Dass Prakash, Pavithra Devi Sendurapandi, Kalaiselvi Periandavan. Assessment of the antidiabetic potential of Gymnemic acid as α-amylase and α-Glucosidase inhibitor using invitro and insilico tools. Research Journal of Pharmacy and Technology. 2021; 14(9):4755-9. doi: 10.52711/0974-360X.2021.00827 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2021-14-9-41
1. Sankaradoss N, Velayutham R, Vijayalakshmi. In Vitro Assay of Alpha amylase Inhibitory Activity of Gymnemic acid Isolated from Gymnema sylvestrae. Der Pharmacia Let. 2016; 8 (20): 29-32.
2. Triveni KB, Lakshmi, VK, Shasshidhara S, Anitha S. Gymnema Sylvestre: A Comprehensive Review. 2012; 3(4): 2402-2420.
3. Mohd. Yaqub Khan, Irfan Aziz, Bipin Bihari, Hemant Kumar, Maryada Roy, Vikas Kumar Verma. A Review- Phytomedicines Used in Treatment of Diabetes. Asian J. Pharm. Res. 4(3): July-Sept. 2014; Page 135-154.
4. P. Jaya Preethi. Herbal Medicine for Diabetes Mellitus: A Review. Asian J. Pharm. Res. 3(2): April- June 2013; Page 57-70.
5. Saeedi P, Petersohn I. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Research and Clinical Practice. 2019; (157): 1-10.
6. Javed Ahamad, Kamran J. Naquvi, Showkat R. Mir, Mohd.Ali, Mohd. Shuaib. Review on Role of Natural Alpha-Glucosidase Inhibitors for Management of Diabetes Mellitus. Int J Biomed Res. 2011; (6): 374-380.
7. Bray GA, Greenway FL. Current and Potential Drugs for Treatment of Obesity. Endocr Rev. 1999; 20(6): 805-875
8. Sankaradoss Nirmala, Velayutham Ravichandiran, A Vijayalakshmi, P. Nadanasabapathi. Protective effect of Gymnemic acid isolated from Gymnema sylvestre leaves coated Chitosan reduced gold nanoparticles in hyperlipedimia and Diabetes Induced vascular tissue damage in Rats. Research J. Pharm. and Tech. 2018; 11(3): 1193-1206. doi: 10.5958/0974-360X.2018.00222.6
9. Amiza, Ghazala Yaseen, Sammia Shahid. Comprehensive Review on Phytopharmacological Potential of Gymnema sylvestre. Asian J. Pharm. Tech. 2020; 10(3):217-220. doi: 10.5958/2231-5713.2020.00036.7
10. Lakshman Kumar D, Rao KNV, Bindu Madhavi, Sathis Kumar D, David Banji. Alpha-Glucosidase Inhibitory Activities of Wrightia tinctoria Roxb and Schrebera swietenoides Roxb Bark Extract. Research J. Pharmacology and Pharmacodynamics. 2011; 3(1): 22-24
11. Zineb Rahmani, Ali Douadi, Zehour Rahmani. In vitro inhibition of α-amylase enzyme, Phytochemical study and Antioxidant capacity for Cupressus sempervirens extracts growing in arid climate. Asian J. Research Chem. 2019; 12(6):359-365. doi: 10.5958/0974-4150.2019.00068.3
12. Vasudev Pai, Rudraprabhu V. Savadi, Anant Bhandarkar. In-Vitro Alpha-Amylase Inhibition Action of Isolated Phytoconstituent in Zanthoxylum rhetsa (Roxb) Bark. Research J. Pharm. and Tech. 4(7): July 2011; Page 1147-1150.
13. Masitah Khamis, Fazilah Talib, Nor Syamira Rosli, Saravanan Dharmaraj, Khamsah Suryati Mohd, Sasidharan Srenivasan, Zubaidi Abdul Latif, Mahadeva Rao S. Utharkar. In vitro α-amylase and α-glucosidase inhibition and increased glucose uptake of Morinda citrifolia fruit and scopoletin. Research J. Pharm. and Tech. 8(2): Feb. 2015; Page 189-193.
14. Peyman S, Behvar A, Mohammad Ali E, Hossein D, Iraj G. α-Glucosidase and α-Amylase Inhibitory Effect and Antioxidant Activity of ten Plant Extracts Traditionally Used in Iran for Diabetes. J Med Plants Res. 2013; 7(6): 257-266
15. Hong L, Toshiaki I, Yasutake H. Inhibitory Effect of Voglibose and Gymnemic Acid on Maltose Absorption in vivo, World J Gastro. 2001; 7(2): 270-274.
16. Guilin C, Mingquan G. Rapid Screening for α-Glucosidase Inhibitors from Gymnema sylvestrae by Affinity Ultrafiltration –HPLC-MS. Front. Pharmacol. 2017; 8: 228.
17. Rashmi S. Harish Prashanth KV, Manonmani HK. In vitro Antidiabetic Effects of Isolated Triterpene Glycoside Fraction from Gymnema sylvestrae. Evi based Comp Alter Med. 2018; 1-12.
18. Mahadeva Rao US, Shanmuga Sundaram C., Srinivasan S. Gymnemic acid mitigates hyperglycemia by attenuating the hepatic glucose metabolic enzymes in high fat diet fed-low dose streptozotocin- induced experimental rodents. doi: 10.5958/0974-360X.2020.00137.7
19. Sinsheimer JE, Manni PE, Constituents from Gymnema sylvestre Leaves. J Pharm Sci. 1965; 54: 1541–1544.
20. Yoshikawa K, Kondo YAS, Matsuura K. Antisweet Natural Products IX Structures of Gymnemic acids XV-XVIII from Gymnema sylvestre. 1993. Chem Pharm Bul. 1993; 41: 1730–1732.
21. Abedulla Khan K, Shabnam D, Mohammed Adil S. Molecular Docking and Preclinical Studies of Gymnema sylvestre on Endothelial Nitric oxide Synthase in type-2 Diabetes-related Complications. J young pharm. 2014; 6(4): 25-32.
22. Roshana Devi V, Sharmila, Subramanian S. Molecular Docking Studies Involving the Inhibitory Effect of Gymnemic Acid, Trigonelline and Ferulic Acid, the Phytochemicals with Antidiabetic Properties, on Glycogen Synthase Kinase 3 (α and β). J App Pharm Sci. 2018; 8 (04): 150-160.
23. Pragya T, Pooja S, Feroz K, Sangwan NS, Mishra BN, Sangwan RS. Structure Activity Relationship Studies of Gymnemic Acid Analogues for Antidiabetic Activity Targeting PPARγ. Cur Comp Aided Drug Des. 2015; 11(1): 57-71.
24. Keisuke S, Yuko K, Noriatsu S, Takatsugu H, Seiji N, Toshiaki I, Yuzo N. Molecular Mechanisms for Sweet-suppressing Effect of Gymnemic Acids. J Bio Chem. 2014; 289(37): 25711–25720.